Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Research demystifies fatal glandular disease
Elderly dog
Cushing's disease is commonly found in older dogs

Researchers identify genetic mutations responsible for Cushing's disease

Researchers from the Toyko Institute of Technology have identified genetic mutations responsible for Cushing's disease, a potentially fatal glandular condition.

Cushing's disease arises from benign tumours of the pituitary gland, which excessively secrete the hormone adrenocorticotropin (ACTH). Symptoms include weight gain, muscular weakness, mood and reproductive problems. If left untreated, patients can die from the resulting infections and cardiovascular problems.

Previous studies sought to identify mutations that might cause the disease through sequencing candidate genes and microarray studies, but these made little progress.

In this study, published in Nature Genetics, the research team applied a particular type of DNA sequencing, known as 'exome sequencing' to the pituitary corticotrophin adenoma.

The scientists exome-sequenced samples from 10 patients with Cushing's disease and noticed a small number of protein altering mutations in the adenoma tissue. They further identified the gene harbouring the mutations as uniquitin-specific protease 8 (USP8), and were able to pinpoint the region of USP8 prone to mutation in Cushing's disease.

Previous studies of Cushing's diseases have highlighted strong expression of another gene, epidermal growth factor receptor (EGFR). By examining EGFR in cells expressing the USP8, the researchers behind this latest research demonstrated that this was the result of USP8 mutations inhibiting downregulation of EGFR.

The researchers say that their results “not only identify the first of so far enigmatic driver mutations in corticotroph adenomas but also elucidate a novel mechanism by which the EGFR pathway is constitutively activated in human tumours.”

The researchers say that further research will be required for a more detailes understanding of genetic onset of the disease. 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.